Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fe40eda58ae8c7c63ace8549d1591e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_564388736955269806e7cb0a216326b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9be95030f7e9b1f0dc582614a74096d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79be7429808968113d4d0ed758513f63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fd7a3336c84106f5a22485b8143bd9f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01F11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01F11-00 |
filingDate |
2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25eaf15dd5ab927f012d4d882f0f9202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af3f652ca5e53e7ed369d5a9cd8a837b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae73a1ac276e22574f9c4b2b0142cb61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7418bfccf94f3b96be7f6e33cf6c0611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a73135bde9f461d6e3e6e40f9e435ffc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52b979b3fca9b5be887ec241e5f82615 |
publicationDate |
2014-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014302145-A1 |
titleOfInvention |
Pharmaceutical composition for treating cancer using carbonate apatite nanoparticles |
abstract |
A principal object of the present invention is to provide a pharmaceutical composition that can produce a high antitumor effect by efficiently delivering a drug with antitumor activity to tumor tissues with the aid of carbonate apatite nanoparticles. The present invention provides a pharmaceutical composition including carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a drug with antitumor activity and a pharmacologically acceptable solvent in which the carbonate apatite nanoparticles containing the drug are dispersed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10214743-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3108890-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9889155-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449155-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3964216-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017088836-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111789866-A |
priorityDate |
2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |